We are international
Donate
• health professionals TEXT SIZE   
webcasts    back

Phase 2 Trial of Single Agent Bortezomib in Patients with Previously Untreated Multiple Myeloma
By Paul G. Richardson, MD
12.12.04
Interview with Dr. Richardson.


 related articles